The Triple-Negative Breast Cancer Treatment Market to Be Driven By Patient Portal Apps
The Triple-Negative Breast Cancer Treatment Market is expected to witness an escalation going forward. With health apps, biosensors, AI, VR, telehealth, robots, cloud computing, predictive analysis, and EHRs being rampantly used, there is nothing to hold the healthcare vertical from soaring high. The healthcare vertical, would, see its cash registers ringing on the count of digital IoT creeping in at a rapid pace. Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the risk of developing cancer before the age of 75 years is around 20.2% and that of dying from cancer before the age of 75 years is around 10.6% . According to the American Cancer Society, in 2019 , around 268,600 new cases of invasive breast cancer were diagnosed among women and approximately 2,670 cases we...